Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04597294 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence

Study acronym: CHIMERA
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 6, 2024 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv9
  2. Interventions: FLOT4 + HIPEC + Surgery (Combination Product), FLOT4 + Surgery (Combination Product) to FLOT + HIPEC + Surgery (Combination Product), FLOT + Surgery (Combination Product)
    • Study description revised
    v8
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 2021 to Aug 1, 2021
    • Site details revised
    v7
  4. Start date: May 2021 to Jul 2021v6
  5. Start date: Apr 2021 to May 2021v5
Show 3 earlier versionsHide 3 earlier versions
  1. Study title shortened, about 2 wordsv4
  2. Start date: Jan 2021 to Apr 2021v3
  3. Study title shortened, about 4 wordsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study was designed to evaluate the efficacy of perioperative FLOT chemotherapy in combination with perioperative hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced gastric cancer at high risk of peritoneal metastases. The impact of treatment on peritoneal recurrence and survival over 6 months, 1, 3 and 5 years will be assessed.
Trial Details
NCT Number NCT04597294
Lead Sponsor Jagiellonian University
Conditions
(from sponsor)		 Gastric Cancer
Related terms Stomach Neoplasms
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov